3-[[2-(4-acetyl-6,7-dihydroxy-3-methyl-9-oxoxanthen-2-yl)-5-carboxy-6,7-dihydroxy-4-oxochromen-3-yl]methyl]-8,9-dihydroxy-2-methyl-4-oxo-5H-pyrano[3,2-c]chromene-10-carboxylic acid

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 黄酮类化合物
• 英文名称: 3-[[2-(4-acetyl-6,7-dihydroxy-3-methyl-9-oxoxanthen-2-yl)-5-carboxy-6,7-dihydroxy-4-oxochromen-3-yl]methyl]-8,9-dihydroxy-2-methyl-4-oxo-5H-pyrano[3,2-c]chromene-10-carboxylic acid
• 化学式: C₄₁H₂₆O₁₈
• 分子量: 806.6
• InChiKey: UPRZYQKXXJOUMY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  59
• 可旋转键数：
  6
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  301
• 氢给体数：
  8
• 氢受体数：
  18

文献信息

• COMPOUNDS AS SEMAPHORIN INHIBITORS
  申请人：Dainippon Sumitomo Pharma Co., Ltd.

  公开号：EP1475382B1

  公开（公告）日：2008-12-10
• Therapeutic or preventive agents for ischemic neuropathy
  申请人：Ikeda Kazuhito

  公开号：US20070105948A1

  公开（公告）日：2007-05-10

  Therapeutic or preventive agents for ischemic nerve injury containing as the active ingredient compounds represented by the general formula [2]: wherein R 1 and R 4 are each independently hydrogen, carboxy, or alkoxycarbonyl; and R 2 and R 5 are each independently hydrogen, hydroxy group, or acyloxy group.
• THERAPEUTIC OR PREVENTIVE AGENTS FOR ISCHEMIC NEUROPATHY
  申请人：IKEDA Kazuhito

  公开号：US20110105599A1

  公开（公告）日：2011-05-05

  Therapeutic or preventive agents for ischemic nerve injury containing as the active ingredient compounds represented by the general formula [2]: wherein R 1 and R 4 are each independently hydrogen, carboxy, or alkoxycarbonyl; and R 2 and R 5 are each independently hydrogen, hydroxy group, or acyloxy group.
• US7642362B2
  申请人：——

  公开号：US7642362B2

  公开（公告）日：2010-01-05